Abstract Categories: Diverse Fields, Unified Goal
Submissions are strongly encouraged across the full spectrum of oncology and cancer genomics. Presenters will be asked to select the category that best fits their research to ensure appropriate review and session placement.
- Cancer Genomics & Epigenomics: This category includes research on gene mutations, structural variants, copy number alterations, DNA methylation, chromatin modifications, and the role of non-coding RNAs in cancer progression and development.
- Bioinformatics & Computational Oncology: Submissions in this area will cover the application of AI and machine learning in cancer diagnosis, prognosis, drug discovery, network modeling, single-cell analysis, and multi-omics data integration.
- Biomarkers & Molecular Diagnostics: This category focuses on the development and application of circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), extracellular vesicles, proteins, and other liquid biopsy components for early detection, minimal residual disease (MRD) monitoring, and treatment response assessment.
- Targeted Therapies & Drug Development: Research on novel molecular targets, small molecule inhibitors, biologics, antibody-drug conjugates (ADCs), radioligand therapies, and innovative early-phase clinical trial designs will be featured.
- Immunotherapy & Tumor Immunology: This section will encompass the genomic aspects of immune evasion, immune checkpoint blockade, CAR-T cell therapies, and the intricate dynamics of the tumor microenvironment.
- Drug Resistance & Tumor Heterogeneity: This category invites research into the mechanisms of acquired and intrinsic drug resistance, the evolution of tumors, and strategies to overcome treatment failure through advanced molecular understanding.
- Translational Research & Clinical Implementation: Submissions will highlight efforts to bridge basic scientific discoveries with their practical application in clinical practice, including the integration of real-world data and the science of implementation.
- Prevention & Early Detection: This area focuses on genomic approaches for cancer risk prediction, screening methodologies, and strategies for cancer interception.
- Pharmacogenomics & Personalized Medicine: Research exploring the genomic determinants of drug response, toxicity, and individualized treatment selection will be included.
- Other Relevant Topics: Submissions on other pertinent areas of oncology and cancer genomics that may not fit neatly into the above categories are also welcome.
The comprehensive and detailed nature of these abstract categories, drawing upon the specific research domains and even individual abstract examples from events like the EACR 2022 Congress , demonstrates the depth and specificity of the scientific content expected. This level of detail is crucial for attracting specialized researchers who seek to present their niche work and for signaling the conference’s ambition to cover the entire translational spectrum of cancer genomics, thereby attracting a diverse range of specialists. It also implicitly highlights the interdisciplinary nature of modern cancer research, where fields like bioinformatics are integral to understanding cancer genomics